Prothena Corp Public (PRTA) Share-based Compensation (2012 - 2026)

Prothena Corp Public's (PRTA) quarterly Share-based Compensation came in at $6.9 million in Q1 2026, down 36.84% year-on-year from $10.9 million in Q1 2025, and down 2.25% quarter-over-quarter from $7.1 million in Q4 2025.

Prothena Corp Public (PRTA) Share-based Compensation (2012 - 2026) Analysis & Trends

Prothena Corp Public's Share-based Compensation history runs 15 years deep, the most recent figure standing at $6.9 million for Q1 2026.

  • On a quarterly basis, Share-based Compensation fell 36.84% year-over-year to $6.9 million in Q1 2026; TTM through Mar 2026 was $33.6 million, a 2861.38% increase from a year earlier, with the FY2025 full-year figure at $37.6 million, up 17245.62% from the prior year.
  • Share-based Compensation slipped to $6.9 million in Q1 2026 per PRTA's latest filing, from $7.1 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $31.2 million in Q4 2022 and bottomed at -$35.2 million in Q4 2024.
  • The 5-year median for Share-based Compensation is $10.1 million (2023), against an average of $8.3 million.
  • Across the five-year window, Share-based Compensation jumped 233.79% in 2022 and tumbled 417.93% in 2024, its largest moves.
  • Year by year, Share-based Compensation stood at $31.2 million in 2022, then sank by 64.45% to $11.1 million in 2023, then tumbled by 417.93% to -$35.2 million in 2024, then soared by 120.08% to $7.1 million in 2025, then fell by 2.25% to $6.9 million in 2026.
  • Per Business Quant, the three latest PRTA Share-based Compensation figures stand at $6.9 million (Q1 2026), $7.1 million (Q4 2025), and $7.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 Prothena Corp Public 458.13 Mn 128.67 Mn - 6.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.92 Mn
Mar 31, 2026 6.92 Mn
Dec 31, 2025 7.07 Mn
Dec 31, 2025 7.07 Mn
Sep 30, 2025 7.20 Mn
Sep 30, 2025 7.20 Mn
Jun 30, 2025 12.42 Mn
Jun 30, 2025 12.42 Mn
Mar 31, 2025 10.95 Mn
Mar 31, 2025 10.95 Mn
Dec 31, 2024 -35.23 Mn
Dec 31, 2024 -35.23 Mn
Sep 30, 2024 11.02 Mn
Sep 30, 2024 11.02 Mn
Jun 30, 2024 12.04 Mn
Jun 30, 2024 12.04 Mn
Mar 31, 2024 12.38 Mn
Mar 31, 2024 12.38 Mn
Dec 31, 2023 11.08 Mn
Dec 31, 2023 11.08 Mn